Intracel Company Profile

14:05 EST 14th December 2018 | BioPortfolio

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma.

Business Strategy

Restructured company to focus on development of immunotherapy products for the treatment of solid tumors
Commercial manufacturing capability for autologous tumor vaccine products
Investment Opportunity

Poised to launch a pivotal study in Stage II colon cancer – estimated market launch in 2010
Rapid follow-on products, based upon experience from pivotal study in colon carcinoma and Phase I/II data in Stage III Colon carcinoma, Renal Carcinoma and Melanoma

Progress in the Past 12 Months

Sterile manufacturing process for autologous cell-based products established
cGMP manufacturing facility approved by Dutch and Swiss Health Authorities
Completed pharmaco-economic analysis - pricing competitive with approved Rx in colon cancer treatment
2006 Milestones


93 Monocacy Blvd. Unit A8
United States of America


Phone: (301) 668-8400
Fax: (301) 668-6317

News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Uptake profiles of human serum exosomes by murine and human tumor cells through combined use of colloidal nanoplasmonics and flow cytofluorimetric analysis.

Understanding extracellular vesicle (EV) internalization mechanisms and pathways in cells is of capital im-portance for both EV basic biology and clinical translation but still presents analytical hur...

TiO2 Nanoparticles Catalyze Oxidation of Huntingtin Exon 1-Derived Peptides Impeding Aggregation: a Quantitative NMR Study of Binding and Kinetics.

Polyglutamine expansion within the N-terminal region of the huntingtin protein results in the formation of intracel-lular aggregates responsible for Huntington's disease, a fatal neurodegenerative con...

Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

Intracel Electrophysiology and Biochemistry Equipment

Established in 1986 INTRACEL has become one of the UK's leading suppliers of equipment for researchers in electrophysiology/transgenesis/ICSI and related disciplines. From the earliest days of the com...

Intracel Corporation

INTRACEL Corporation is a biopharmaceutical company developing and commercializing cancer vaccines and immunotherapeutic products for cancer and infectious diseases. The company has built a large por...


Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immu...

More Information about "Intracel" on BioPortfolio

We have published hundreds of Intracel news stories on BioPortfolio along with dozens of Intracel Clinical Trials and PubMed Articles about Intracel for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intracel Companies in our database. You can also find out about relevant Intracel Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record